Trinity Biotech Share Holder Equity 2010-2024 | TRIB
Trinity Biotech share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
| Trinity Biotech Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023 | $-24 |
| 2022 | $-2 |
| 2021 | $0 |
| 2020 | $-2 |
| 2019 | $5 |
| 2018 | $44 |
| 2017 | $65 |
| 2016 | $109 |
| 2015 | $214 |
| 2014 | $197 |
| 2013 | $183 |
| 2012 | $169 |
| 2011 | $151 |
| 2010 | $141 |
| 2009 | $79 |
| Trinity Biotech Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-26 |
| 2024-06-30 | $-29 |
| 2024-03-31 | $-23 |
| 2023-12-31 | $-24 |
| 2023-09-30 | $-17 |
| 2023-06-30 | $-11 |
| 2023-03-31 | $-7 |
| 2022-12-31 | $-2 |
| 2022-09-30 | $7 |
| 2022-06-30 | $16 |
| 2022-03-31 | $-6 |
| 2021-12-31 | $0 |
| 2021-09-30 | $1 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $-2 |
| 2020-09-30 | $7 |
| 2020-06-30 | $-1 |
| 2020-03-31 | $1 |
| 2019-12-31 | $5 |
| 2019-09-30 | $39 |
| 2019-06-30 | $39 |
| 2019-03-31 | $44 |
| 2018-12-31 | $44 |
| 2018-09-30 | $68 |
| 2018-06-30 | $67 |
| 2018-03-31 | $66 |
| 2017-12-31 | $65 |
| 2017-09-30 | $106 |
| 2017-06-30 | $107 |
| 2017-03-31 | $109 |
| 2016-12-31 | $109 |
| 2016-09-30 | $210 |
| 2016-06-30 | $211 |
| 2016-03-31 | $212 |
| 2015-12-31 | $214 |
| 2015-09-30 | $211 |
| 2015-06-30 | $205 |
| 2015-03-31 | $201 |
| 2014-12-31 | $197 |
| 2014-09-30 | $195 |
| 2014-06-30 | $196 |
| 2014-03-31 | $189 |
| 2013-12-31 | $183 |
| 2013-09-30 | $175 |
| 2013-06-30 | $175 |
| 2013-03-31 | $175 |
| 2012-12-31 | $169 |
| 2012-09-30 | $165 |
| 2012-06-30 | $160 |
| 2012-03-31 | $159 |
| 2011-12-31 | $151 |
| 2011-09-30 | $149 |
| 2011-06-30 | $147 |
| 2011-03-31 | $145 |
| 2010-12-31 | $141 |
| 2010-09-30 | $137 |
| 2010-06-30 | $133 |
| 2010-03-31 | $82 |
| 2009-12-31 | $79 |
| 2009-09-30 | $76 |
| 2009-06-30 | $72 |
| 2009-03-31 | $67 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.011B | $0.062B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.693B | 27.62 |
| Boston Scientific (BSX) | United States | $154.617B | 38.71 |
| Stryker (SYK) | United States | $145.191B | 30.36 |
| EssilorLuxottica (ESLOY) | France | $128.660B | 0.00 |
| Medtronic (MDT) | Ireland | $104.194B | 14.77 |
| Haleon (HLN) | United Kingdom | $50.678B | 28.85 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.121B | 0.00 |
| ResMed (RMD) | United States | $35.889B | 26.96 |
| GE HealthCare Technologies (GEHC) | United States | $32.579B | 15.47 |
| Agilent Technologies (A) | United States | $31.612B | 20.53 |
| Terumo (TRUMY) | Japan | $27.743B | 36.03 |
| Insulet (PODD) | United States | $22.770B | 89.38 |
| Koninklijke Philips (PHG) | Netherlands | $21.553B | 15.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.259B | 11.73 |
| Baxter (BAX) | United States | $15.693B | 11.72 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.530B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.236B | 21.70 |
| Lantheus Holdings (LNTH) | United States | $5.132B | 12.95 |
| Prestige Consumer Healthcare (PBH) | United States | $4.168B | 18.62 |
| Perrigo (PRGO) | Ireland | $3.726B | 9.44 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.248B | 14.79 |
| ICU Medical (ICUI) | United States | $3.162B | 23.32 |
| Envista Holdings (NVST) | United States | $3.141B | 26.10 |
| GN Store Nord (GNNDY) | Denmark | $2.200B | 18.22 |
| QuidelOrtho (QDEL) | United States | $2.144B | 14.74 |
| LeMaitre Vascular (LMAT) | United States | $1.830B | 40.91 |
| AtriCure (ATRC) | United States | $1.660B | 0.00 |
| Acuren (TIC) | United States | $1.336B | 0.00 |
| Neogen (NEOG) | United States | $1.326B | 16.97 |
| AdaptHealth (AHCO) | United States | $1.225B | 12.44 |
| Kestra Medical Technologies (KMTS) | United States | $1.174B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.103B | 24.81 |
| BioLife Solutions (BLFS) | United States | $1.062B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.993B | 12.69 |
| InMode (INMD) | Israel | $0.910B | 9.17 |
| CeriBell (CBLL) | United States | $0.621B | 0.00 |
| Evolus (EOLS) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.593B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.533B | 0.00 |
| Owens & Minor (OMI) | United States | $0.504B | 4.18 |
| Capricor Therapeutics (CAPR) | United States | $0.486B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Surmodics (SRDX) | United States | $0.418B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.325B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.324B | 11.91 |
| Aurora Cannabis (ACB) | Canada | $0.310B | 55.20 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.90 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.14 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.240B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.236B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.211B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.207B | 0.00 |
| Quanterix (QTRX) | United States | $0.205B | 0.00 |
| Brainsway (BWAY) | Israel | $0.202B | 53.50 |
| Biote (BTMD) | United States | $0.193B | 5.43 |
| Omeros (OMER) | United States | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| High Tide (HITI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.30 |
| Exagen (XGN) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 16.62 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.119B | 0.00 |
| Agape ATP (ATPC) | $0.093B | 0.00 | |
| Fonar (FONR) | United States | $0.089B | 11.48 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.077B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.45 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.74 |
| Safety Shot (SHOT) | United States | $0.026B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |